Scholar Rock Holding Corp (SRRK)
12.48
-1.84
(-12.85%)
USD |
NASDAQ |
May 17, 16:00
11.85
-0.63
(-5.05%)
After-Hours: 20:00
Scholar Rock Cash from Financing (Quarterly): 6.525M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.525M |
December 31, 2023 | 96.53M |
September 30, 2023 | 0.28M |
June 30, 2023 | 4.689M |
March 31, 2023 | 1.076M |
December 31, 2022 | -0.97M |
September 30, 2022 | -0.451M |
June 30, 2022 | 195.77M |
March 31, 2022 | 0.481M |
December 31, 2021 | 39.70M |
September 30, 2021 | 1.906M |
June 30, 2021 | 0.607M |
March 31, 2021 | 2.737M |
December 31, 2020 | 246.46M |
September 30, 2020 | 0.368M |
Date | Value |
---|---|
June 30, 2020 | 0.595M |
March 31, 2020 | 0.399M |
December 31, 2019 | 0.818M |
September 30, 2019 | 6.124M |
June 30, 2019 | 42.10M |
March 31, 2019 | -0.157M |
December 31, 2018 | 16.93M |
September 30, 2018 | -1.464M |
June 30, 2018 | 78.97M |
March 31, 2018 | -0.167M |
December 31, 2017 | 46.72M |
September 30, 2017 | -0.167M |
June 30, 2017 | 4.119M |
March 31, 2017 | -0.167M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.97M
Minimum
Dec 2022
246.46M
Maximum
Dec 2020
32.29M
Average
1.491M
Median
Cash from Financing (Quarterly) Benchmarks
Amgen Inc | -1.708B |
Eli Lilly and Co | -311.30M |
Ocular Therapeutix Inc | 321.22M |
Alpine Immune Sciences Inc | 19.35M |
X4 Pharmaceuticals Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -49.78M |
Cash from Investing (Quarterly) | 33.38M |
Free Cash Flow | -152.02M |
Free Cash Flow Per Share (Quarterly) | -0.5194 |
Free Cash Flow Yield | -13.92% |